`Magic pill` for men with aggressive prostate cancer
London: A study from the Institute of Cancer Research based in London and Surrey indicates that a potentially life-prolonging pill for men with aggressive prostate cancer could be available within a year.
The abiraterone acetate drug, for which phase three trials were halted on ethical grounds, will offer new hope to men with advanced prostate cancer.
The study has important implications because currently men with this aggressive type of prostate cancer currently have very few treatment options and a poor prognosis.
Risk of death was reduced by 35percent in men receiving abiraterone while survival was increased by 36 percent from a midpoint of 10.9 to 14.8 months.
“The news that abiraterone acetate may extend survival with manageable side-effects will be incredibly important to men with prostate cancer and their families," Sky News quoted study leader Dr Johan de Bono as saying.
Results from the trial have been presented at the European Society for Medical Oncology Congress in Milan, Italy.
More from India
More from World
More from Sports
More from Entertaiment
- Panel discussion over vote bank politics on Hinduism
- Pak High Commission staffer grilled for spying, asked to leave India
- Panel discussion on the need of Pakistan's ambassador in India
- DNA: Zee Media's campaign to celebrate Diwali with soldier's family
- Ceasefire violations by Pak: Should India carry out surgical strike part-II?
- Pakistan's brutality exposed; `Black Day` protesters thrashed in PoK - Video goes viral
- Pakistan High Commission staffer, briefly detained for espionage, asked to leave India in 48 hours
- Pakistan declares Indian High Commission official persona non grata, asks him to leave country
- VIRAL VIDEO: Damn cute! Why this 9-week-old's full head of hair is shocking the internet - WATCH
- I may not be with CM Akhilesh Yadav, but will always be with Mulayam Singh Yadav's son: Amar Singh